KakaoBank’s rapid growth is threatening traditional banks in South Korea, who now have to strengthen their online platforms, according to Moody’s Investors Service.
Moody’s noted that the internet-only bank now has the largest number of users.
It attributed its rapid asset growth to unsecured personal lending, straightforward digital banking experience, and lower costs by using technological advancements and doing away with physical branches.
Kakao Bank’s cost/income ratio is 0.5 percent lower than the asset-weighted average of the country's four largest banks and 3.9 percent points lower than the six regional banks.
Moody’s noted that competition will intensify as KakaoBank expands its loan portfolio and capital base.
KakaoBank's plan to launch mortgages and merchant loan products will expand its addressable market from 14 percent to 65 percent of South Korea’s won-denominated loans in the next 12-18 months.
KakaoBank’s planned initial public offering in the second half of 2021 could increase its capital by around 76 percent-90 percent compared to the end of March.


Platinum Price Surges Past $2,000 as Demand and Supply Dynamics Tighten
IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
German Exports to the U.S. Decline Sharply as Tariffs Reshape Trade in 2025
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Asian Stock Markets Trade Flat as Holiday Liquidity Thins and BOJ Minutes Watched
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Yen Stabilizes Near Lows as Japan Signals Readiness to Intervene Amid Dollar Weakness
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Gold Price Breaks $4,500 as Safe-Haven Demand and Rate Cut Bets Fuel Rally
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
China’s Power Market Revamp Fuels Global Boom in Energy Storage Batteries 



